Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss may target specific pathways and generate new hair follicles.

The gel made of minoxidil and hydroxypropyl-β-cyclodextrin improves hair growth and is good for long-term use.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

Dynamic, light touch is sensed through a common mechanism involving Piezo2 channels in sensory axons.

Fractional lasers could help hair regrowth in androgenic alopecia, but more research is needed to confirm their effectiveness and safety.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

SM-215 promotes hair growth by improving the environment around hair follicles.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Various treatments help hair growth, but more research needed for safety and effectiveness.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Mouse touch-sensitive nerve cells adjust their connections based on competition with other similar cells.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.